Direct-to-Consumer Models for Prescription Drug Coverage: A New Trend in Coverage for GLP-1s

The cost of GLP-1 medications to group health plans continues to increase rapidly as FDA approval expands and the percentage of participants and beneficiaries taking GLP-1 medications rises. This trend is creating significant financial pressure for plan sponsors, prompting a reevaluation of how GLP-1 medications for weight loss are covered. We previously discussed the balance between providing GLP-1 coverage...... By: Verrill